Vaccine News and Research

Latest Vaccine News and Research

Neutralizing antibodies produced following COVID-19 BNT162b2 vaccine found to activate complement cascade

Neutralizing antibodies produced following COVID-19 BNT162b2 vaccine found to activate complement cascade

The generation of SARS-CoV-2 virus-like particles in insect cells

The generation of SARS-CoV-2 virus-like particles in insect cells

Development of prioritization tool to further the role of equity in global COVID-19 vaccine allocation

Development of prioritization tool to further the role of equity in global COVID-19 vaccine allocation

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

SARS-CoV-2-specific T cells are broader after vaccination than after infection

SARS-CoV-2-specific T cells are broader after vaccination than after infection

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

Weill Cornell Medicine honors students, staff for exemplary efforts to promote diversity and inclusion

Weill Cornell Medicine honors students, staff for exemplary efforts to promote diversity and inclusion

SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

Serious Shortage Protocols issued to limit the dispensing of 3 Hormone Replacement Therapy products

Serious Shortage Protocols issued to limit the dispensing of 3 Hormone Replacement Therapy products

Safety and immunogenicity of three-dose vaccination with the Pfizer/BioNtech SARS-CoV-2 mRNA vaccine

Safety and immunogenicity of three-dose vaccination with the Pfizer/BioNtech SARS-CoV-2 mRNA vaccine

Identifying the immunological correlate of protection to predict the efficacy of new coronavirus vaccines

Identifying the immunological correlate of protection to predict the efficacy of new coronavirus vaccines

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants

Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants

Lower COVID-19 mortality among physically active individuals in Sub-Saharan Africa

Lower COVID-19 mortality among physically active individuals in Sub-Saharan Africa

Study reports an orally available SARS-CoV-2 Mpro inhibitor with potent in vivo antiviral activity

Study reports an orally available SARS-CoV-2 Mpro inhibitor with potent in vivo antiviral activity

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

Sartorius Launches the Octet® SF3 SPR System, Strengthening its Leadership in Advanced Label-Free Bioanalytics

Sartorius Launches the Octet® SF3 SPR System, Strengthening its Leadership in Advanced Label-Free Bioanalytics

Improving Medical Communication through Social Media

Improving Medical Communication through Social Media

Study shows polysaccharides of seaweed and abalone inhibit SARS-CoV-2 in vitro

Study shows polysaccharides of seaweed and abalone inhibit SARS-CoV-2 in vitro

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.